BMY
Bristol-Myers Squibb Company
Revenue by region
2025, ended Dec 31, 2025
Earlier:
Regions by fiscal year
| USDLine, in USD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 33.3B | 34.1B | 31.2B | 31.5B | 29.2B | 26.6B | 15.3B | 12.6B | 11.4B | 10.7B | 8.2B | 7.7B | 8.3B | 10.4B | 14.0B | 12.8B | 11.9B |
| International | 13.8B | 13.2B | 13.1B | 13.8B | 16.3B | 15.3B | 6.3B | 5.7B | 5.0B | 4.2B | — | — | — | — | — | — | — |
| Other | 1.09B | 1.00B | 0.70B | 0.83B | 0.85B | 0.63B | 0.52B | 0.58B | 0.55B | 0.53B | 0.74B | 1.11B | 0.84B | 0.33B | 89M | 0.11B | 0.20B |
| — | — | — | — | — | — | 4.01B | 3.73B | 3.88B | 3.96B | 7.63B | 7.05B | 7.23B | 6.91B | 7.12B | 6.57B | 6.74B | |
| Rest of the World | — | — | — | — | — | — | 4.01B | 3.73B | 3.88B | 3.96B | 4.14B | 3.46B | 3.30B | 3.20B | 3.24B | 2.90B | — |
| Europe | — | — | — | — | — | — | — | — | — | — | 3.49B | 3.59B | 3.93B | 3.71B | 3.88B | 3.67B | 3.63B |
| Japan, Asia Pacific, and Canada | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.52B |
| Latin America, Middle East And Africa | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 843M |
| Emerging Markets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 753M |
| Total | 48.2B | 48.3B | 45.0B | 46.2B | 46.4B | 42.5B | 26.1B | 22.6B | 20.8B | 19.4B | 16.6B | 15.9B | 16.4B | 17.6B | 21.2B | 19.5B | 18.8B |